West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript July 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 1,165,777 | $255,072,008 | 1.62% | |
| 2. | Durable Capital Partners Henry Ellenbogen | 1,040,648 | $227,693,782 | -34% | 1.72% |
| 3. | Millennium Management Israel Englander | 465,587 | $101,870,436 | +53% | 0.05% |
| 4. | Bill & Melinda Gates Foundation Trust Michael Larson | 444,500 | $97,256,600 | 0.2% | |
| 5. | Point72 Asset Management Steve Cohen | 339,953 | $74,381,793 | +165% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | $5,677.40 | 66,251 | 2019-02-28 | Filing | |
| $110.55 | 57 | $6,301.52 | 66,197 | 2018-07-31 | Filing | |
| $93.94 | 335 | $31,468.79 | 66,475 | 2017-10-17 | Filing | |
| $88.89 | 275 | $24,444.31 | 56,540 | 2018-05-15 | Filing | |
| $84.53 | 332 | $28,063.30 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | $69,840.00 | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | $148,371.20 | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | $150,000.00 | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | $158,700.00 | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | $225,772.64 | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,316,804 | $2,038,516,715 | 0.03% | |
| 2. | 6,604,922 | $1,445,156,967 | 0.03% | |
| 3. | 3,271,866 | $715,884,281 | 0.03% | |
| 4. | 3,206,381 | $701,556,276 | 0.13% | |
| 5. | 3,021,283 | $661,063,722 | 0.87% |
News See All
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks
West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025.
10 Most Oversold S&P 500 Stocks So Far in 2025
The S&P 500 Index has delivered a strong performance in 2025 as it has climbed over 7% and reached new all-time highs.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on WST.
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market?
Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services (WST) Fell on Lowered Guidance
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST)?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. After a strong start to 2025, U.S.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Swiss Transparent Portfolio’s Substack. In this article, we will summarize the bulls’ thesis on WST.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on WST.
West Pharmaceutical Services (WST) Fell on Disappointing Guidance
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
